METAVANT Trademark

Trademark Overview


On Monday, April 23, 2018, a trademark application was filed for METAVANT with the United States Patent and Trademark Office. The USPTO has given the METAVANT trademark a serial number of 79235207. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 9, 2026. This trademark is owned by Metavant Sciences GmbH. The METAVANT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific and technological services as well as research and design services relating thereto, namely, scientific research and development and product research and development; pharmaceutical and biomedical research services; research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; provision of information regarding scientific research in the field of pharmaceuticals and biomedicine

Provision of health information and medical information; provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, disorders and pathologies

General Information


Serial Number79235207
Word MarkMETAVANT
Filing DateMonday, April 23, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 9, 2026
Registration Number5784144
Registration DateTuesday, June 25, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements


Goods and ServicesScientific and technological services as well as research and design services relating thereto, namely, scientific research and development and product research and development; pharmaceutical and biomedical research services; research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; provision of information regarding scientific research in the field of pharmaceuticals and biomedicine
Goods and ServicesProvision of health information and medical information; provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, disorders and pathologies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 9, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 9, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMetavant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressCH-4051 Basel
CH

Party NameMetavant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressCH-4051 Basel
CH

Party NameMetavant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressCH-4051 Basel
CH

Trademark Events


Event DateEvent Description
Thursday, June 28, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 6, 2018APPLICATION FILING RECEIPT MAILED
Monday, August 13, 2018ASSIGNED TO EXAMINER
Tuesday, August 14, 2018NON-FINAL ACTION WRITTEN
Wednesday, August 15, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 23, 2018REFUSAL PROCESSED BY MPU
Thursday, August 23, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 30, 2018NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 7, 2018REFUSAL PROCESSED BY IB
Thursday, December 20, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, January 24, 2019CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Wednesday, January 30, 2019ATTORNEY REVIEW COMPLETED
Wednesday, February 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 8, 2019ASSIGNED TO LIE
Thursday, February 14, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 25, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, September 30, 2019FINAL DISPOSITION PROCESSED
Monday, September 30, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 18, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 25, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 11, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 9, 2026CANCELLED SECTION 71